Conference Proceedings

IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) plus chemotherapy

S Peters, AW Kim, B Solomon, DR Gandara, R Dziadziuszko, A Brunelli, MC Garassino, M Reck, L Wang, I To, SW Sun, BJ Gitlitz, A Sandler, N Rizvi

ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2019

Grants

Funding Acknowledgements

F. Hoffmann-La Roche, Ltd.